한글목차

세계의 원격 유전체학 시장은 2024년에 3억 8,881만 달러로 평가되었으며, 2030년까지 CAGR 8.01%로 성장하여 6억 1,734만 달러에 달할 것으로 예측됩니다.

세계 원격 유전체학 시장은 원격의료와 유전체 분석의 통합을 통해 유전자 검사, 상담, 해석 서비스를 원격으로 제공하는 시장을 말합니다. 이 시장의 확대는 주로 통신 인프라의 지속적인 발전으로 인해 원활한 원격 상담과 효율적인 데이터 전송이 가능해짐에 따라 추진되고 있습니다. 또한, 유전적 지식을 통한 조기 발견 및 위험 평가 강화를 필요로 하는 만성질환의 전 세계적인 발생률 증가는 원격 유전체학 솔루션에 대한 수요를 크게 증가시키고 있습니다.

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 원격 유전체학 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 서비스별(온디맨드 액세스, 유전자 평가, 검사 의뢰, 전문가 팔로업)
  • 전문 분야별(암 유전학, 심장 유전학, 예방적 유전학, 생식 유전학, 기타)
  • 최종사용자별(환자와 그 가족, 의료 전문가, 의료·제약 기업, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 원격 유전체학 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 원격 유전체학 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 원격 유전체학 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 원격 유전체학 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 원격 유전체학 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 원격 유전체학 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Genome Medical, Inc.
• FDNA, Inc.
• Illumina, Inc.
• Informed Medical Decisions, Inc
• Invitae Corporation
• Pacific Radiopharmacy, Ltd.
• NTP Radioisotopes SOC Ltd.
• Lantheus Medical Imaging, Inc.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Tele-genomics Market, valued at USD 388.81 Million in 2024, is projected to experience a CAGR of 8.01% to reach USD 617.34 Million by 2030. The Global Tele-genomics Market encompasses the delivery of genetic testing, counseling, and interpretation services remotely through the integration of telemedicine and genomic analysis. This market's expansion is primarily driven by continuous advancements in telecommunication infrastructure, which facilitate seamless remote consultations and efficient data transmission. Furthermore, the rising global incidence of chronic diseases, requiring enhanced early detection and risk assessment through genetic insights, significantly fuels the demand for tele-genomics solutions.

Key Market Drivers

The increasing prevalence of chronic and genetic diseases constitutes a significant driver for the global tele-genomics market, necessitating more accessible and efficient diagnostic and counseling services. Conditions like heart disease, cancer, and diabetes, often with genetic predispositions, drive demand for early detection, risk assessment, and personalized treatment. According to the Centers for Disease Control and Prevention, in February 2024, an estimated 129 million people in the United States have at least one major chronic disease, with 42 percent affected by two or more, highlighting a substantial patient population poised for proactive genetic screening and personalized management. Tele-genomics directly addresses geographical and logistical barriers to specialized genetic services, enabling remote patient engagement vital for managing these widespread health challenges.

Key Market Challenges

The inherent complexity of data privacy concerns and the fragmented regulatory landscape across various jurisdictions represent a substantial impediment to the growth of the Global Tele-genomics Market. The highly sensitive nature of genomic information necessitates robust privacy frameworks. However, the absence of harmonized international and even intra-national regulations creates significant challenges for the secure and interoperable exchange of this critical data. This regulatory divergence complicates cross-border service delivery and hinders the establishment of standardized data sharing protocols, which are essential for large-scale genomic research and clinical application.

Key Market Trends

Two significant trends driving the global tele-genomics market are the increasing adoption of AI-powered genomic interpretation for remote consultations and the enhanced interoperability and data standardization for remote genomic platforms. Artificial intelligence is transforming the analysis of complex genomic data, making remote consultations more efficient and precise. This is evident as nearly 30% of the funding poured into healthcare startups in 2024 went to companies leveraging artificial intelligence, according to Silicon Valley Bank. Such investments underscore the growing recognition of AI's capability to process vast datasets and extract meaningful insights. AI-powered genomics has enabled precision medicine with 17.6% higher diagnostic accuracy in breast cancer detection, as reported by Forbes in September 2025. This directly translates into improved diagnostic services deliverable through tele-genomics.

Key Market Players

• Genome Medical, Inc.
• FDNA, Inc.
• Illumina, Inc.
• Informed Medical Decisions, Inc
• Invitae Corporation
• Pacific Radiopharmacy, Ltd.
• NTP Radioisotopes SOC Ltd.
• Lantheus Medical Imaging, Inc.

Report Scope:

In this report, the Global Tele-genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tele-genomics Market, By Services:

• On-Demand Access
• Genetic Assessment
• Test Ordering
• Expert Follow-Up

Tele-genomics Market, By Specialties:

• Cancer Genetics
• Cardio Genetics
• Proactive Genetics
• Reproductive Genetics
• Others

Tele-genomics Market, By End User:

• Patients & Their Families
• Health Professionals
• Health & Pharma Companies
• Others

Tele-genomics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Tele-genomics Market.

Available Customizations:

Global Tele-genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tele-genomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Services (On-Demand Access, Genetic Assessment, Test Ordering, Expert Follow-Up)
  • 5.2.2. By Specialties (Cancer Genetics, Cardio Genetics, Proactive Genetics, Reproductive Genetics, Others)
  • 5.2.3. By End User (Patients & Their Families, Health Professionals, Health & Pharma Companies, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Tele-genomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Services
  • 6.2.2. By Specialties
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Tele-genomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Services
      • 6.3.1.2.2. By Specialties
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Tele-genomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Services
      • 6.3.2.2.2. By Specialties
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Tele-genomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Services
      • 6.3.3.2.2. By Specialties
      • 6.3.3.2.3. By End User

7. Europe Tele-genomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Services
  • 7.2.2. By Specialties
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Tele-genomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Services
      • 7.3.1.2.2. By Specialties
      • 7.3.1.2.3. By End User
  • 7.3.2. France Tele-genomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Services
      • 7.3.2.2.2. By Specialties
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Tele-genomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Services
      • 7.3.3.2.2. By Specialties
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Tele-genomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Services
      • 7.3.4.2.2. By Specialties
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Tele-genomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Services
      • 7.3.5.2.2. By Specialties
      • 7.3.5.2.3. By End User

8. Asia Pacific Tele-genomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Services
  • 8.2.2. By Specialties
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Tele-genomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Services
      • 8.3.1.2.2. By Specialties
      • 8.3.1.2.3. By End User
  • 8.3.2. India Tele-genomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Services
      • 8.3.2.2.2. By Specialties
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Tele-genomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Services
      • 8.3.3.2.2. By Specialties
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Tele-genomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Services
      • 8.3.4.2.2. By Specialties
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Tele-genomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Services
      • 8.3.5.2.2. By Specialties
      • 8.3.5.2.3. By End User

9. Middle East & Africa Tele-genomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Services
  • 9.2.2. By Specialties
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Tele-genomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Services
      • 9.3.1.2.2. By Specialties
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Tele-genomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Services
      • 9.3.2.2.2. By Specialties
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Tele-genomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Services
      • 9.3.3.2.2. By Specialties
      • 9.3.3.2.3. By End User

10. South America Tele-genomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Services
  • 10.2.2. By Specialties
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Tele-genomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Services
      • 10.3.1.2.2. By Specialties
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Tele-genomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Services
      • 10.3.2.2.2. By Specialties
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Tele-genomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Services
      • 10.3.3.2.2. By Specialties
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Tele-genomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Genome Medical, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. FDNA, Inc.
• 15.3. Illumina, Inc.
• 15.4. Informed Medical Decisions, Inc
• 15.5. Invitae Corporation
• 15.6. Pacific Radiopharmacy, Ltd.
• 15.7. NTP Radioisotopes SOC Ltd.
• 15.8. Lantheus Medical Imaging, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer